Summary of Key Highlights
At this year's Shanghai International Trade Fair (SITIF), two Chinese companies specializing in advanced hardware technology—Huihe Medical and Sophis Intelligent Technology—presented innovative solutions to industry-specific challenges. Huihe’s interventional tricuspid valve device has made open-heart surgery less invasive, while Sophis’ AI-powered grinding solution has addressed the shortage of skilled labor in manufacturing. These innovations have not only been rapidly commercialized (with some already generating profits or doubling sales) but also demonstrate a global perspective, with targets including the European Union and the United States. Behind these successes are China’s well-developed industrial chain, specialized and innovative teams, and supportive government policies.
I. Advanced Technology Solving Real Industry Problems
The innovations from both companies address long-standing issues in their respective sectors:
- Medical Field: Minimizing Invasive Tricuspid Valve Surgery
Traditional open-heart surgeries for tricuspid valve patients carry high risks, yet China sees over 100,000 new cases each year. Huihe’s device replaces the traditional approach with an interventional procedure through a 5-millimeter incision, allowing patients to be discharged the next day. Compared to foreign products that require 17 anchors, Huihe’s solution uses only one, significantly reducing surgery time and achieving precision at the sub-millimeter level (0.1 millimeters).
- Industrial Field: AI-Driven Grinding
Manufacturing grinding jobs are dusty and noisy, making them unattractive to young workers, even with salaries of 20,000–30,000 RMB per month. Sophis’ AI system equips the equipment with multi-dimensional sensors that analyze data in real-time, ensuring precision within 0.8 micrometers (thousands of times finer than a human hair) while increasing efficiency by 50%. The operation is also simple to learn; trainees with a secondary vocational education can start working in just 1–2 days, and the system “memorizes” the settings, eliminating the need for repeated adjustments.
II. Rapid Commercialization
These innovations have moved beyond the laboratory stage and are generating revenue:
- Huihe Medical: Six Years to Certification, Profit Expected This Year
Typically, it takes 10 years for high-risk medical devices to go from development to certification, but Huihe has completed this process in just six years, thanks to Shanghai’s streamlined evaluation processes for innovative devices. Their products have been used in over 100 hospitals, treating hundreds of patients, with a goal of performing 1,000 surgeries this year. The company expects to generate revenue in 2024 and is preparing to list on the STAR Market (China’s science and technology innovation board).
- Sophis: Replacing Manual Labor, Customers Buying Enthusiastically
One set of Sophis’ equipment can replace three to four workers, with a payback period of 18 months. Companies such as Seres, BMW, and Dalian Heavy Industry are already using or planning to use their products. Last year, domestic sales amounted to about 100 million RMB, with expectations for a doubling this year.
III. Global Ambition from the Start
These companies have been global from their inception:
- Huihe: Targeting the EU and US Markets
Huihe is working on obtaining CE certification (the European Union’s safety standard) and expects to complete it by the end of the year, while also preparing for FDA certification in the US. Their products have been showcased at top academic conferences in the UK and Germany, and they were recognized as an innovative product by the American Heart Association for 2024. Their patents cover multiple countries, including China, the US, and Europe.
- Sophis: Expanding Internationally
The founders are participating in exhibitions in the US and have previously visited Singapore and Vietnam to discuss partnerships with overseas agents.
- SITIF as a Platform for International Connections
This year’s SITIF featured dual host cities from China and abroad (Lausanne, Switzerland, and a city cluster in Scotland, UK), along with an international exhibition area featuring 74 foreign companies, helping these companies connect with global resources.
IV. The Driving Forces Behind Innovation
The rapid development of these advanced technologies is supported by three key factors:
- Well-Developed Industrial Chain: Capacity for Production
China’s robust supply chain enables companies to produce precision parts quickly, reducing the need for imports.
- Policy Support
Shanghai’s evaluation system for innovative medical devices simplifies the process of getting them approved for use in hospitals, and there are additional incentives for specialized and innovative enterprises.
- Specialized and Innovative Teams
Both Huihe and Sophis have teams focused on cutting-edge research and development. Huihe has applied for over 200 patents (60% of which are invention patents), while Sophis collaborates with academia and industry in areas such as aerospace and new energy.
These examples demonstrate that Chinese hard technology companies are transitioning from following international leaders to taking the lead, solving domestic problems while competing in global markets. The key lies in identifying real industry challenges and leveraging a supportive industrial chain and policy environment to accelerate growth.